Perlmutter Cancer Center

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

• Conditions:
  Hormone Receptor Positive, Her-2 Negative Advanced/metastatic Breast Cancer Patients
• Age: Between 18 - 100 Years
• Gender: Male or Female

• Other Inclusion Criteria:
  

  1) ECOG Performance Status of 0 or 1. 2) Histologic or cytologic diagnosis of metastatic breast cancer. 3) Has received no more than two lines of prior hormonal therapy for advanced nonresectable/ metastatic disease or no more than two lines of prior chemotherapy for advanced nonresectable/ metastatic disease.
  

You may not be eligible for this study if the following are true:

• 1) Is currently receiving an investigational agent or has received an investigational agent or used an investigational device within 28 days of study registration. 2) Has a diagnosis of immunodeficiency or is receiving systemic steroid therapy or any other form of immunosuppressive therapy within 7 days prior to study registration. 3) Has a known history of Human Immunodeficiency Virus (HIV) (HIV 1/2 antibodies).